METROSIN R 2.5 TABLET

Product Description

METROSIN R 2.5 TABLET Dual Action Therapy for Effective Blood Pressure & Heart Health Management

METROSIN R 2.5 TABLET is a powerful cardiovascular combination therapy containing Metoprolol Succinate (SR) 25mg and Ramipril 2.5mg. This once-daily tablet delivers synergistic control of hypertension, reduces the risk of cardiac events, and supports long-term heart health with sustained-release beta-blocker and ACE inhibitor action.

Key Benefits:

• Effectively lowers high blood pressure and maintains cardiovascular stability

• Reduces risk of heart attack, stroke, and heart failure

• Metoprolol (SR) ensures steady beta-blocker action throughout the day

• Ramipril helps relax blood vessels and improves heart function

• Ideal for patients with hypertension, post-MI care, or chronic heart failure

Recommended Usage:
Prescribed for essential hypertension, post-myocardial infarction recovery, and heart failure management. Trusted by cardiologists and general physicians for long-term cardiovascular therapy.

Why Choose METROSIN R 2.5 TABLET?
Formulated for therapeutic efficacy and patient compliance, METROSIN R 2.5 is an essential addition to any cardiovascular product line. Perfect for pharma distributors, bulk buyers, hospitals, and medical retailers looking for reliable chronic care solutions.

Strengthen your cardiology range with METROSIN R 2.5 TABLET trusted by doctors, preferred by patients. Contact us today for bulk supply and B2B distribution opportunities.